13F HOLDINGS REPORT
SYQUANT CAPITAL SAS
Quarter ended Q2 2023 · Filed April 12, 2023 · Accession 0001766392-23-000002
Total Value
$43,156
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HORIZON THERAPEUTICS PUB L | G46188101 | 271,617 | $29,644 | 68.69% |
| 2 | MONEYGRAM INTL INC | 60935Y208 | 448,200 | $4,670 | 10.82% |
| 3 | AMRYT PHARMA PLC | 03217L106 | 258,000 | $3,762 | 8.72% |
| 4 | APOLLO ENDOSURGERY INC | 03767D108 | 300,000 | $2,976 | 6.90% |
| 5 | MANCHESTER UTD PLC NEW | G5784H106 | 50,000 | $1,108 | 2.57% |
| 6 | TECHNIPFMC PLC | FTI | 53,000 | $723 | 1.68% |
| 7 | FERRARI N V | RACE | 1,010 | $273 | 0.63% |